Publikationen

Designing an Improved T-cell Mobilising CXCL10 Mutant Through Enhanced GAG Binding Affinity

Gerlza T, Trojacher C, Jeremic D, Krieger E, Adage T, Kungl A.

PEGylation of a Glycosaminoglycan-Binding, Dominant-Negative CXCL8 Mutant Retains Bioactivity in Vitro and in Vivo

Meyer NH, Dellago H, Tam-Amersdorfer C, et al.

Structural Fuzziness of the RNA-Organizing Protein SERF Determines a Toxic Gain-of-interaction

Eustace AD, McNaughton EF, King S, et al.

Soluble syndecan-3 Binds Chemokines, Reduces Leukocyte Migration in Vitro and Ameliorates Disease Severity in Models of Rheumatoid Arthritis

Merle DA, Witternigg A, Tam-Amersdorfer C, et al.

Increased Aggregation Tendency of Alpha-Synuclein in a Fully Disordered Protein Complex

Winkler S, Derler R, Gesslbauer B, Krieger E, Kungl AJ.

Molecular Dynamics Simulations of the Chemokine CCL2 in Complex With Pull Down-Derived Heparan Sulfate Hexasaccharides

Almer J, Gesslbauer B, Kungl AJ.

Therapeutic strategies to target microbial protein-glycosaminoglycan interactions

Vanheule V, Crijns H, Poosti F, et al.

Anti-inflammatory effects of the GAG-binding CXCL9(74-103) peptide in dinitrofluorobenzene-induced contact hypersensitivity in mice

Novel Anti-Inflammatory Peptides Based on Chemokine-Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis

Derler R, Gesslbauer B, Weber C, Strutzmann E, Miller I, Kungl A.

Glycosaminoglycan-Mediated Downstream Signaling of CXCL8 Binding to Endothelial Cells

Vanheule V, Boff D, Mortier A, et al.

CXCL9-Derived Peptides Differentially Inhibit Neutrophil Migration In Vivo through Interference with Glycosaminoglycan Interactions

Weitere Informationen